EVO
Evotec SE
A drug discovery and development partner headquartered in Hamburg, Germany, Evotec helps pharmaceutical and biotechnology companies turn early ideas into clinical-ready drug candidates through its research platforms. It was founded in 1993 as Evotec BioSystems by a team that included Nobel Prize-winning chemist Manfred Eigen, and its name blends "evolutionary biology" and "technology" — a nod to Eigen's belief that evolution's principles could guide drug discovery.
ADRUnderlying: EVOCUSIP: 30050E105HealthcareDE
American Depositary Shares, each representing one-half of one ordinary share
No tracked superinvestors held this security in this period.